Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice

Journal of Pathology

Volumn 214, Issue 4, 2008, Pages 472-481

  Xu, J ^a,c   Qu, J ^a   Cao, L ^b   Sai, Y ^b   Chen, C ^b   He, L ^a   Yu, L ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Angiopoietin 1; Gene therapy; Lipopolysaccharide; Lung injury; Mesenchymal stem cells

Indexed keywords

ANGIOPOIETIN 1; BACTERIUM LIPOPOLYSACCHARIDE; LENTIVIRUS VECTOR; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSDUCTION; INBRED STRAIN; INFLAMMATORY CELL; LUNG BLOOD VESSEL; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL GENE THERAPY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANGIOPOIETIN-1; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; LENTIVIRUS; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; PEROXIDASE; PHENOTYPE; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40349103688     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2302     Document Type: Article

References (42)

1. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Resp Crit Care Med 2003;167:1027-1035.
2. Jeyaseelan S, Chu HW, Young SK, Worthen GS. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 2004;72:7247-7256.
3. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145-156.
4. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
5. Kim I, Oh JL, Ryu YS, So JN, Sessa WC, Walsh K et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J 2002;16:126-128.
6. Cho CH, Kammerer RA, Lee HJ, Yasunaga K, Kim KT, Choi HH et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci USA 2004;101:5553- 5558.
7. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-2486.
8. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005;111:97-105.
9. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000;87:603-607.
10. Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 2003;139:329-336.
11. Karmpaliotis D, Kosmidou I, Ingenito EP, Hong K, Malhotra A, Sunday ME et al. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002;283:L585-595.
12. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Resp Crit Care Med 2007;175:1014-1026.
13. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483-3493.
14. Korbling M, Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept. N Engl J Med 2003;349:570-582.
15. Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003;100:2397-2404.
16. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407-8411.
17. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Resp Cell Mol Biol 2005;33:145-152.
18. Denburg JA, van Eeden SF. Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology. Eur Resp J 2006;27:441-445.
19. Stripp BR, Shapiro SD. Stem cells in lung disease, repair, and the potential for therapeutic interventions: state-of-the-art and future challenges. Am J Resp Cell Mol Biol 2006;34:517-518.
20. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
21. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 2004;556:249-252.
22. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numazaki M, Ueda S et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 2004;172:1266- 1272.
23. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Resp Crit Care Med 2006;173:171-179.
24. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
25. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005;5:1571-1584.
26. Polak J, Hench L. Gene therapy progress and prospects in tissue engineering. Gene Ther 2005;12:1725-1733.
27. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-1603.
28. Jiang S, Haider HK, Idris NM, Salim A, Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 2006;99:776-784.
29. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Resp Cell Mol Biol 2005;33:328-334.
30. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan Al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20.
31. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
32. Hanawa H, Kelly PF, Nathwani AC, Persons DA, Vandergriff JA, Hargrove P et al. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 2002;5:242-251.
33. Ingenito EP, Mora R, Cullivan M, Marzan Y, Haley K, Mark L et al. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Resp Cell Mol Biol 2001;25:35- 44.
34. Xu JF, Qu JM, He LX, Ou ZL. Impaired upregulation of keratinocyte growth factor in injured lungs induced by Pseudomonas aeruginosa in immunosuppressed rats. Chin Med J (Engl) 2006;119(17):1421-1429.
35. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JGN. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L1026- 1032.
36. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005;100:810-816.
37. Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell types under minimal damage conditions. J Cell Sci 2004;117:5655-5664.
38. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
39. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intra-pulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007;179:1855-1863.
40. Van Damme A, Thorrez L, Ma L, Vandenburgh H, Eyckmans J, Dell'Accio F et al. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 2006;24:896-907.
41. McCarter SD, Lai PF, Suen RS, Stewart DJ. Regulation of endothelin-1 by angiopoietin-1: implications for Inflammation. Exp Biol Med 2006;231:985-991.
42. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007;282:23910-23918.